Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Elizabeth Jacobs

Orthopaedic Surgery Orlando, FL Medical Doctor

NPI 1558717207 CMS profile 11466217

60 Columbia St Ste 400, Orlando, FL 32806

Open in the dashboard

General payments

$65,566

152 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elizabeth Jacobs of Orlando, FL is reported in the CMS Open Payments database as having received $65,566 across 152 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $39,584 58
2024 General $8,271 47
2023 General $17,685 46
2022 General $26 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Jacobs
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Elizabeth Jacobs were reported at $39,584. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Elizabeth Jacobs Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $26 $598 $128–$2,731 $149
2023 $17,685 $461 $128–$2,264 $160
2024 $8,271 $497 $134–$2,475 $164
2025 $39,584 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Smith+Nephew, Inc. $49,623 85 payments
  2. Arthrex, Inc. $10,000 1 payment
  3. Stryker Corporation $4,178 42 payments
  4. Zimmer Biomet Holdings, Inc. $387 5 payments
  5. Integra LifeSciences Corporation $356 3 payments
  6. Globus Medical, Inc. $310 3 payments
  7. Medinc of Texas $243 2 payments
  8. Orthofix Medical, Inc. $140 2 payments
  9. Piramal Critical Care $122 1 payment
  10. DePuy Synthes Sales Inc. $55 2 payments
  11. Other $152 6 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Consulting Fee $21,591 4 payments
  2. Travel and Lodging $11,367 29 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,025 1 payment
  4. Grant $10,000 1 payment
  5. Food and Beverage $8,212 115 payments
  6. Education $3,125 1 payment
  7. Long term medical supply or device loan $245 1 payment
Products named General payments · program years 2022–2025
  1. REAL INTELLIGENCE $39,922 47 payments
  2. JOURNEY II Recon Knees $29,058 40 payments
  3. JOURNEY II Recon Knees $20,702 5 payments
  4. JOURNEY II Recon Knees $18,966 2 payments
  5. LEGION Revision $13,240 16 payments
  6. PICO $11,042 2 payments
  7. OR3O Dual Mobility $11,025 1 payment
  8. LEGION $11,025 1 payment
  9. JOURNEY II Recon Knees $10,500 2 payments
  10. JOURNEY $10,041 1 payment
  11. Other $26,208 200 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 86 billing codes

Paid by Medicare

$153,350

Medicare's payments for the services billed

Medicare patients

263

Average age 77

Services billed

727

190 women, 73 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 70%
Diabetes 41%
Ischemic heart disease 40%
Chronic kidney disease 40%
Depression 40%
Atrial fibrillation 32%
Heart failure 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

152 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record